Drugs to Watch 2024

Drugs to Watch Listing 2024 - Clarivate

A listing of the 13 standout new drugs spotlighted in the Clarivate Drugs to Watch 2024 report.

5 new weight-loss drugs to watch in the fight for the next Ozempic

Novo Nordisk, Eli Lilly, Viking Therapeutics and more are publishing promising trial results. In the race to find Ozempic 2.0, a few stand-outs ...

Top 10 most anticipated drug launches of 2024 - Fierce Pharma

Top 10 most anticipated drug launches of 2024 · 1. KarXT · 2. Donanemab · 3. Resmetirom · 4. Sotatercept · 5. Datopotamab deruxtecan · 6. Acoramidis.

Pipeline Drugs to Watch Report Q4 2024 - Business Caremark

Anticipated availability in 4Q 2024 or 1Q 2025. Yorvipath is the only FDA-approved exogenous parathyroid hormone product and provides a ...

13 Therapies Make Clarivate's 2024 Drugs to Watch List - BioSpace

This year, 13 molecules made it to the 2024 Drugs to Watch list, the majority of them approved for oncology and rare diseases.

10 clinical trials to watch in the second half of 2024 - BioPharma Dive

Drugmakers are also looking at dual-targeting antibody drugs, with similar goals. A Roche drug known as mosunetuzumab could be the first to ...

What sets the Drugs to Watch in 2024 apart - Clarivate

The annual Clarivate Drugs to Watch report for 2024 features 13 new therapeutics with standout commercial and/or clinical potential.

Novel Drug Approvals for 2024 - FDA

FDA Novel Drug Therapy Approvals for 2024 ; 28. Niktimvo, axatilimab-csfr, 8/14/2024, To treat chronic graft-versus-host disease (cGVHD) ; 27. Livdelzi ...

New Drugs and Therapies That May Be Approved in 2024 and 2025

There are several highly anticipated treatments that may be FDA approved in 2024 or 2025. Zepbound (tirzepatide) for obstructive sleep apnea, ...

Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data - Xtalks

This blog delves into the top 30 drugs to watch in 2024, leveraging insights from their sales performance in 2023.

Pipeline Drugs to Watch Report Q3 2024 - Business Caremark

Oral. Sun Pharma. The treatment of moderate-to-severe alopecia areata in adults. Pending. FDA approval. 07/06/2024. Litfulo (ritlecitinib) oral.

Eight newly approved drugs that could become blockbusters in 2024

Johnson & Johnson's niraparib and abiraterone acetate, more commonly known as AKEEGA, was one of the new drugs to make it to the list.

Thirteen potential blockbuster drugs to watch in 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve 'blockbuster' status by 2029 or deliver game-changing benefits to patients.

Pipeline Update: Top 10 New Drugs to Watch in 2024 - Xevant

Pipeline Update: Top 10 New Drugs to Watch in 2024 ... Manufacturers are actively seeking approval from the U.S. Food & Drug Administration (FDA) ...

FDA decisions to watch in 2024 | Pharma Manufacturing

FDA decisions to watch in 2024 · 1. Eli Lilly's donanemab · 2. Madrigal Pharmaceuticals' resmetirom · 3. Merck's sotatercept · 4. ImmunityBio's ...

2024: A new year promises a host of new drugs - LinkedIn

Biosimilar drug trends ... Scott: Speaking of drug development, another big development we saw in 2023 was the arrival of a slate of biosimilar ...

Clarivate Identifies Thirteen Potential Blockbuster Drugs and ...

Access the Drugs to Watch 2024 report from Clarivate, here. For more Drugs to Watch updates and analyses throughout the year, visit the Drugs ...

Drugs to Watch 2024

In this 2024 edition of Drugs to Watch, we highlight some of the trends that will be consequential to the discovery, development and delivery of ...

2024's Most Influential Drug and Vaccine Approvals So Far - GoodRx

Wegovy (semaglutide), Tryvio (aprocitentan), and Ohtuvayre (ensifentrine) are three of the many innovative medications that gained new approvals in 2024. They' ...

5 volatile drug launches to watch in 2024

Not all of these upcoming drug launches are consensus analyst picks, but they're all expected to create volatility in some way.